Skip to main content
OpenTrials

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

701 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

NCT04150497

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
  • University of Colorado - Aurora Cancer Center Aurora, Colorado, United States
  • Sarah Cannon - Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View all 19 locations
View Trial Details
Recruiting

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

NCT06882057

Conditions
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Chongqing Medical University Affiliated Children's Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 27 locations
View Trial Details
Recruiting

A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

NCT05667506

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
  • Nanfang Hospital Guangzhou, Guangdong, China
View Trial Details
Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

NCT03509961

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Children's of Alabama/University of Alabama in Birmingham(UAB) Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 24 locations
View Trial Details

Related conditions